Immunohistochemistry analysis of these tumor sections revealed that ELAVL3 deficiency inhibited cell proliferation, induced apoptosis, and caused a lineage switch from the neuroendocrine to luminal phenotype (Fig. 2i). This evidence concerns the gene ELAVL3 and neoplasm.